These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8558338)

  • 1. Natal status of infants of cocaine users and control subjects: a prospective comparison.
    Hurt H; Brodsky NL; Braitman LE; Giannetta J
    J Perinatol; 1995; 15(4):297-304. PubMed ID: 8558338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine/polydrug use in pregnancy: two-year follow-up.
    Chasnoff IJ; Griffith DR; Freier C; Murray J
    Pediatrics; 1992 Feb; 89(2):284-9. PubMed ID: 1370867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-care utilization among mothers and infants following cocaine exposure.
    Shankaran S; Bauer CR; Bada HS; Lester B; Wright LL; Das A
    J Perinatol; 2003; 23(5):361-7. PubMed ID: 12847529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain growth among fetuses exposed to cocaine in utero: asymmetrical growth retardation.
    Little BB; Snell LM
    Obstet Gynecol; 1991 Mar; 77(3):361-4. PubMed ID: 1992399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute neonatal effects of cocaine exposure during pregnancy.
    Bauer CR; Langer JC; Shankaran S; Bada HS; Lester B; Wright LL; Krause-Steinrauf H; Smeriglio VL; Finnegan LP; Maza PL; Verter J
    Arch Pediatr Adolesc Med; 2005 Sep; 159(9):824-34. PubMed ID: 16143741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cohort study of alkaloidal cocaine ("crack") in pregnancy.
    Cherukuri R; Minkoff H; Feldman J; Parekh A; Glass L
    Obstet Gynecol; 1988 Aug; 72(2):147-51. PubMed ID: 3393357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birth outcomes for infants of drug abusing mothers.
    Kaye K; Elkind L; Goldberg D; Tytun A
    N Y State J Med; 1989 May; 89(5):256-61. PubMed ID: 2733887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of substance abuse during pregnancy and infant outcome.
    Little BB; Snell LM; Van Beveren TT; Crowell RB; Trayler S; Johnston WL
    Am J Perinatol; 2003 Jul; 20(5):255-62. PubMed ID: 13680509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine-exposed children: follow-up through 30 months.
    Hurt H; Brodsky NL; Betancourt L; Braitman LE; Malmud E; Giannetta J
    J Dev Behav Pediatr; 1995 Feb; 16(1):29-35. PubMed ID: 7730454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal effects of amphetamine and heroin use during pregnancy on the mother and infant.
    Thaithumyanon P; Limpongsanurak S; Praisuwanna P; Punnahitanon S
    J Med Assoc Thai; 2005 Nov; 88(11):1506-13. PubMed ID: 16471094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine use in women from a defined population: prevalence at delivery and effects on growth in infants.
    Weathers WT; Crane MM; Sauvain KJ; Blackhurst DW
    Pediatrics; 1993 Feb; 91(2):350-4. PubMed ID: 8424009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcome and infant development following gestational cocaine use by social cocaine users in Toronto, Canada.
    Graham K; Feigenbaum A; Pastuszak A; Nulman I; Weksberg R; Einarson T; Goldberg S; Ashby S; Koren G
    Clin Invest Med; 1992 Aug; 15(4):384-94. PubMed ID: 1516296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine cocaine exposure and the risk for sudden infant death syndrome: a meta-analysis.
    Fares I; McCulloch KM; Raju TN
    J Perinatol; 1997; 17(3):179-82. PubMed ID: 9210070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological correlates of fetal cocaine exposure: transient hypertonia of infancy and early childhood.
    Chiriboga CA; Vibbert M; Malouf R; Suarez MS; Abrams EJ; Heagarty MC; Brust JC; Hauser WA
    Pediatrics; 1995 Dec; 96(6):1070-7. PubMed ID: 7491223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between congenital heart defects and small for gestational age.
    Malik S; Cleves MA; Zhao W; Correa A; Hobbs CA;
    Pediatrics; 2007 Apr; 119(4):e976-82. PubMed ID: 17387169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study.
    Riaz M; Porat R; Brodsky NL; Hurt H
    J Perinatol; 1998; 18(6 Pt 1):449-54. PubMed ID: 9848759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of intrauterine cocaine exposure on the respiratory status of the very low birth weight infant.
    Hand IL; Noble L; McVeigh TJ; Kim M; Yoon JJ
    J Perinatol; 2001 Sep; 21(6):372-5. PubMed ID: 11593371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polydrug-using adolescent mothers and their infants receiving early intervention.
    Field TM; Scafidi F; Pickens J; Prodromidis M; Pelaez-Nogueras M; Torquati J; Wilcox H; Malphurs J; Schanberg S; Kuhn C
    Adolescence; 1998; 33(129):117-43. PubMed ID: 9583666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early dyadic patterns of mother-infant interactions and outcomes of prematurity at 18 months.
    Forcada-Guex M; Pierrehumbert B; Borghini A; Moessinger A; Muller-Nix C
    Pediatrics; 2006 Jul; 118(1):e107-14. PubMed ID: 16818525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.